| Year |
Citation |
Score |
| 1995 |
Acri JB, Brown KJ, Saah MI, Grunberg NE. Strain and age differences in acoustic startle responses and effects of nicotine in rats. Pharmacology, Biochemistry, and Behavior. 50: 191-8. PMID 7740057 DOI: 10.1016/0091-3057(94)00285-Q |
0.697 |
|
| 1994 |
Acri JB. Nicotine modulates effects of stress on acoustic startle reflexes in rats: dependence on dose, stressor and initial reactivity Psychopharmacology. 116: 255-265. PMID 7892414 DOI: 10.1007/Bf02245326 |
0.643 |
|
| 1994 |
Acri JB, Morse DE, Popke EJ, Grunberg NE. Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats. Psychopharmacology. 114: 369-74. PMID 7838931 DOI: 10.1007/Bf02244861 |
0.692 |
|
| 1994 |
Popke E, Acri JB, Grunberg NE. Nicotine, stress, and acoustic startle responses of rats Pharmacology Biochemistry and Behavior. 48: 835. DOI: 10.1016/0091-3057(94)90397-2 |
0.683 |
|
| 1993 |
Acri JB, Nespor S, Brown K, Grunberg NE. Interactions of stress and nicotine on PPI and acoustic startle Pharmacology Biochemistry and Behavior. 46: 505. DOI: 10.1016/0091-3057(93)90428-V |
0.673 |
|
| 1993 |
Acri JB, Saah MI, Brown KJ, Grunberg NE. Effects of age, strain, and nicotine on rats' acoustic startle Pharmacology Biochemistry and Behavior. 46: 505. DOI: 10.1016/0091-3057(93)90427-U |
0.675 |
|
| 1992 |
Acri JB, Grunberg NE. A psychophysical task to quantify smoking cessation-induced irritability: the reactive irritability scale (RIS). Addictive Behaviors. 17: 587-601. PMID 1488939 DOI: 10.1016/0306-4603(92)90068-7 |
0.599 |
|
| 1991 |
Acri JB, Grunberg NE, Morse DE. Effects of nicotine on the acoustic startle reflex amplitude in rats. Psychopharmacology. 104: 244-8. PMID 1876669 DOI: 10.1007/Bf02244186 |
0.727 |
|
| 1991 |
Grunberg NE, Acri JB. Conceptual and methodological considerations for tobacco addiction research. British Journal of Addiction. 86: 637-41. PMID 1859932 DOI: 10.1111/J.1360-0443.1991.Tb01822.X |
0.666 |
|
| 1991 |
Acri JB, Grunberg NE. A psychophysical task to quantify smoking cesation-induced irritability Pharmacology Biochemistry and Behavior. 39: 240. DOI: 10.1016/0091-3057(91)90495-N |
0.54 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1996 |
Acri JB, Serdikoff SL, Witkin JM, Sannerud CA. Discriminative stimulus effects of the benzodiazepine receptor partial agonist bretazenil in pigeons and in rats. Behavioural Pharmacology. 7: 72-77. PMID 11224396 |
0.272 |
|
| 2007 |
Elkashef A, Biswas J, Acri JB, Vocci F. Biotechnology and the treatment of addictive disorders: New opportunities Biodrugs. 21: 259-267. PMID 17628123 DOI: 10.2165/00063030-200721040-00006 |
0.244 |
|
| 1997 |
Witkin JM, Acri JB, Gleeson S, Barrett JE. Blockade of behavioral effects of bretazenil by flumazenil and ZK 93,426 in pigeons. Pharmacology, Biochemistry, and Behavior. 56: 1-7. PMID 8981602 DOI: 10.1016/S0091-3057(96)00120-7 |
0.175 |
|
| 2001 |
Miller DK, Crooks PA, Teng L, Witkin JM, Munzar P, Goldberg SR, Acri JB, Dwoskin LP. Lobeline inhibits the neurochemical and behavioral effects of amphetamine. The Journal of Pharmacology and Experimental Therapeutics. 296: 1023-34. PMID 11181937 |
0.169 |
|
| 1995 |
Acri JB, Wong G, Witkin JM. Stereospecific transduction of behavioral effects via diazepam-insensitive GABAA receptors. European Journal of Pharmacology. 278: 213-23. PMID 7589157 DOI: 10.1016/0014-2999(95)00128-8 |
0.139 |
|
| 2001 |
Acri JB, Thompson AC, Shippenberg T. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Synapse (New York, N.Y.). 39: 343-50. PMID 11169785 DOI: 10.1002/1098-2396(20010315)39:4<343::Aid-Syn1018>3.0.Co;2-Q |
0.114 |
|
| 1996 |
Witkin JM, Acri JB, Wong G, Gleeson S, Barrett JE. Behavioral and biochemical characterization of benzodiazepine receptor partial agonists in pigeons. The Journal of Pharmacology and Experimental Therapeutics. 277: 87-96. PMID 8613971 |
0.113 |
|
| 2017 |
Appel N, Acri J. An Assessment of the Cardiovascular Safety of the Dopamine D 3 Receptor Antagonist GSK598809 with Cocaine in Telemetered Dogs and Rats Journal of Pharmacological and Toxicological Methods. 88: 220. DOI: 10.1016/J.VASCN.2017.09.170 |
0.113 |
|
| 2005 |
Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: The state of the science American Journal of Psychiatry. 162: 1432-1440. PMID 16055764 DOI: 10.1176/appi.ajp.162.8.1432 |
0.111 |
|
| 1997 |
Acri JB, Wong G, Lyon T, Witkin JM, Basile AS. Localization and pharmacological characterization of pigeon diazepam-insensitive GABAA receptors. Neuroscience. 77: 371-8. PMID 9472397 DOI: 10.1016/S0306-4522(96)00469-1 |
0.105 |
|
| 1998 |
Izenwasser S, Acri JB, Kunko PM, Shippenberg T. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Synapse (New York, N.Y.). 30: 275-83. PMID 9776131 DOI: 10.1002/(Sici)1098-2396(199811)30:3<275::Aid-Syn5>3.0.Co;2-8 |
0.103 |
|
| 1996 |
Acri JB, Siedleck BK, Witkin JM. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine. The Journal of Pharmacology and Experimental Therapeutics. 277: 198-206. PMID 8613919 |
0.102 |
|
| 2016 |
Acri JB, Cross AJ, Skolnick P. From bench to bedside: mGluR2 positive allosteric modulators as medications to treat substance use disorders. Psychopharmacology. PMID 27995279 DOI: 10.1007/s00213-016-4501-9 |
0.099 |
|
| 1995 |
Witkin JM, Acri JB. Effects of ifenprodil on stimulatory, discriminative stimulus, and convulsant effects of cocaine. Behavioural Pharmacology. 6: 245-253. PMID 11224333 |
0.087 |
|
| 2016 |
Egli M, White DA, Acri JB. Considerations in the Evaluation of Potential Efficacy of Medications for Alcohol and Drug Use Disorders: An Editorial. International Review of Neurobiology. 126: 1-14. PMID 27055609 DOI: 10.1016/bs.irn.2016.02.007 |
0.085 |
|
| 1996 |
Acri JB, Shah JH, Newman AH, Belov YP, Basile AS, Sharpe LG, Witkin JM. Behavioral effects and dopamine antagonist properties of N-alkylaminobenzazepines Drug Development Research. 37: 39-47. DOI: 10.1002/(Sici)1098-2299(199601)37:1<39::Aid-Ddr2>3.0.Co;2-N |
0.082 |
|
| 1995 |
Acri JB, Carter SR, Alling K, Geter-Douglass B, Dijkstra D, Wikström H, Katz JL, Witkin JM. Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands. European Journal of Pharmacology. 281: R7-9. PMID 7589197 DOI: 10.1016/0014-2999(95)00411-D |
0.077 |
|
| 2013 |
Acri J. Evidence for the Contribution of D4 Receptors to Cocaine Self-Administration in Monkeys Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 180. DOI: 10.1016/B978-0-12-800044-1.00162-8 |
0.064 |
|
| 2008 |
McCann DJ, Acri JB, Vocci FJ. Drug discovery and development for reward disorders: Views from government Animal and Translational Models For Cns Drug Discovery. 3: 23-40. DOI: 10.1016/B978-0-12-373861-5.00022-9 |
0.062 |
|
| 1998 |
Witkin J, Gasior M, Acri J, Beekman M, Thurkauf A, Yuan J, DeBoer P, Wikström H, Dijkstra D. Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907. European Journal of Pharmacology. 347: R1-3. PMID 9741997 DOI: 10.1016/S0014-2999(98)00174-5 |
0.059 |
|
| 2014 |
Appel N, Acri J, McCann D. Specialized preclinical safety pharmacology studies for stimulant abuse therapeutics Journal of Pharmacological and Toxicological Methods. 70: 357. DOI: 10.1016/j.vascn.2014.03.164 |
0.057 |
|
| 1997 |
Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists. The Journal of Pharmacology and Experimental Therapeutics. 283: 7-15. PMID 9336302 |
0.055 |
|
| 2015 |
Appel NM, Li SH, Holmes TH, Acri JB. Dopamine D3 Receptor Antagonist (GSK598809) potentiates the hypertensive effects of cocaine in conscious, freely-moving dogs Journal of Pharmacology and Experimental Therapeutics. 354: 484-492. DOI: 10.1124/jpet.115.224121 |
0.051 |
|
| 2008 |
Acri JB. Introduction to a Symposium on Recent Advances in the Development of Medications for Drug Abuse Treatment in Honor of Jack H. Mendelson, MD Experimental and Clinical Psychopharmacology. 16: 443-445. PMID 19086765 DOI: 10.1037/a0014102 |
0.048 |
|
| 2018 |
Rasmussen K, White DA, Acri JB. NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30538289 DOI: 10.1038/s41386-018-0292-5 |
0.032 |
|
| 2018 |
Appel NM, Acri JB. Cardiovascular safety studies on dopamine D3 receptor antagonists and cocaine Journal of Pharmacological and Toxicological Methods. 93: 156. DOI: 10.1016/J.VASCN.2018.01.511 |
0.03 |
|
| 2015 |
Skolnick P, White D, Acri JB. Synopsis of expert opinions and conclusions Cns and Neurological Disorders - Drug Targets. 14: 773-776. |
0.012 |
|
| 2015 |
Skolnick P, White D, Acri JB. Editorial: Emerging Targets for Stimulant Use Disorders: Where To Invest In An Era Of Constrained Resources? Cns & Neurological Disorders Drug Targets. 14: 691. PMID 26073937 DOI: 10.2174/187152731406150624122404 |
0.01 |
|
| 2015 |
Skolnick P, White D, Acri JB. Emerging targets for stimulant use disorders: Where to invest in an era of constrained resources? Cns and Neurological Disorders - Drug Targets. 14: 691. |
0.01 |
|
| 2008 |
Acri JB, Chiang CN, McCann DJ, Shih ML, Vocci FJ. Summary of NIDA medications workshop: new opportunities for chemists and pharmacologists Drug and Alcohol Dependence. 92: 307-311. PMID 18286704 DOI: 10.1016/j.drugalcdep.2007.05.020 |
0.01 |
|
| Hide low-probability matches. |